Open dataset · CC BY 4.0
Peptide discussion volume and sentiment by compound
Post counts and mean sentiment per peptide compound, computed over a continuously ingested corpus of public Reddit and X discussion classified by MyPeptideStory. Aggregate counts only — no post text, author identifiers or permalinks are included. Groups with fewer than five underlying posts are suppressed.
How to read this
Sentiment is our own classifier's output, not a validated instrument. Volume reflects what people chose to post, which is not prevalence of use — people who experience nothing rarely write about it. Mean sentiment across compounds sits in a narrow band, so differences of a few hundredths are not meaningful.
Aggregate counts only. No post text, author identifiers or permalinks are published here or in the CSV. Any group with fewer than 5 underlying posts is suppressed rather than reported, which is both a privacy control and a statistical one — a share derived from four posts is noise.
| Compound | Posts | X | Mean sentiment | Positive % | Negative % | |
|---|---|---|---|---|---|---|
| Tirzepatide | 1672 | 1535 | 137 | 0.216 | 40.6 | 16.7 |
| Semaglutide | 573 | 485 | 88 | 0.189 | 38.9 | 18.8 |
| Retatrutide | 516 | 261 | 255 | 0.266 | 40.5 | 11 |
| BPC-157 | 506 | 118 | 388 | 0.19 | 37 | 17.4 |
| MOTS-c | 342 | 140 | 202 | 0.343 | 44.2 | 7 |
| GHK-Cu | 341 | 202 | 139 | 0.219 | 35.2 | 11.7 |
| KPV | 262 | 111 | 151 | 0.192 | 34.4 | 11.8 |
| Semax | 211 | 127 | 84 | 0.339 | 44.5 | 9 |
| Tesamorelin | 200 | 95 | 105 | 0.312 | 41.5 | 6 |
| CJC-1295 / Ipamorelin | 180 | 100 | 80 | 0.373 | 48.3 | 6.7 |
| Selank | 156 | 102 | 54 | 0.306 | 47.4 | 14.1 |
| TB-500 | 155 | 61 | 94 | 0.253 | 38.1 | 13.5 |
| Epitalon | 148 | 30 | 118 | 0.249 | 34.5 | 8.8 |
| Cerebrolysin | 101 | 49 | 52 | 0.259 | 37.6 | 8.9 |
| DSIP | 74 | 30 | 44 | 0.288 | 40.5 | 5.4 |
| Melanotan-II | 64 | 30 | 34 | 0.086 | 21.9 | 17.2 |
| Oxytocin | 42 | 10 | 32 | 0.278 | 31 | 0 |
| Dihexa | 41 | 6 | 35 | 0.26 | 39 | 9.8 |
| Sermorelin | 39 | 33 | 6 | 0.314 | 46.2 | 10.3 |
| 5-Amino-1MQ | 31 | 8 | 23 | 0.172 | 32.3 | 6.5 |
| Orforglipron | 25 | 6 | 19 | 0.341 | 52 | 12 |
| Kisspeptin | 24 | 12 | 12 | 0.335 | 41.7 | 4.2 |
| PT-141 | 20 | 9 | 11 | 0.052 | 35 | 25 |
| AOD-9604 | 12 | 9 | 3 | 0.347 | 50 | 0 |
| CagriSema | 12 | 0 | 12 | 0.25 | 25 | 0 |
| MK-677 (Ibutamoren) | 9 | 8 | 1 | 0.333 | 33.3 | 0 |
| Larazotide | 5 | 3 | 2 | 0.066 | 20 | 0 |
| FOXO4-DRI | 5 | 2 | 3 | -0.466 | 0 | 60 |
| SNAP-8 | 5 | 0 | 5 | 0 | 0 | 0 |
Licence and citation
Published under CC BY 4.0. Use it, including commercially, with attribution.
MyPeptideStory. Peptide discussion volume and sentiment by compound. 2026. https://www.mypeptidestory.com/data/peptide-discussion-volume-sentiment
Richer cuts — outcome verdicts, discontinuation reasons, supply-channel splits and time series — are part of Peptide Signal.